Agenus Inc (AGEN)
11.71
+0.24
(+2.09%)
USD |
NASDAQ |
May 09, 16:00
11.75
+0.04
(+0.34%)
After-Hours: 20:00
Agenus Market Cap: 245.28M for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 245.28M |
| May 08, 2024 | 240.25M |
| May 07, 2024 | 251.56M |
| May 06, 2024 | 271.25M |
| May 03, 2024 | 273.76M |
| May 02, 2024 | 262.24M |
| May 01, 2024 | 277.74M |
| April 30, 2024 | 253.87M |
| April 29, 2024 | 267.27M |
| April 26, 2024 | 244.86M |
| April 25, 2024 | 173.85M |
| April 24, 2024 | 155.42M |
| April 23, 2024 | 135.31M |
| April 22, 2024 | 120.86M |
| April 19, 2024 | 111.22M |
| April 18, 2024 | 104.10M |
| April 17, 2024 | 113.11M |
| April 16, 2024 | 131.96M |
| April 15, 2024 | 136.15M |
| April 12, 2024 | 170.71M |
| April 11, 2024 | 185.79M |
| April 10, 2024 | 186.88M |
| April 09, 2024 | 203.80M |
| April 08, 2024 | 195.01M |
| April 05, 2024 | 211.01M |
| Date | Value |
|---|---|
| April 04, 2024 | 211.93M |
| April 03, 2024 | 222.07M |
| April 02, 2024 | 214.49M |
| April 01, 2024 | 246.12M |
| March 28, 2024 | 242.97M |
| March 27, 2024 | 233.09M |
| March 26, 2024 | 224.71M |
| March 25, 2024 | 233.92M |
| March 22, 2024 | 228.77M |
| March 21, 2024 | 235.52M |
| March 20, 2024 | 232.33M |
| March 19, 2024 | 235.68M |
| March 18, 2024 | 221.90M |
| March 15, 2024 | 226.22M |
| March 14, 2024 | 251.23M |
| March 13, 2024 | 275.90M |
| March 12, 2024 | 280.34M |
| March 11, 2024 | 282.10M |
| March 08, 2024 | 280.72M |
| March 07, 2024 | 280.04M |
| March 06, 2024 | 279.56M |
| March 05, 2024 | 268.46M |
| March 04, 2024 | 272.41M |
| March 01, 2024 | 263.62M |
| February 29, 2024 | 267.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
104.10M
Minimum
Apr 18 2024
1.516B
Maximum
Aug 30 2021
616.71M
Average
598.30M
Median
Apr 07 2021
Market Cap Benchmarks
| Protalix BioTherapeutics Inc | 91.32M |
| InfuSystems Holdings Inc | 160.76M |
| PAVmed Inc | 21.22M |
| Allogene Therapeutics Inc | 483.60M |
| Pfizer Inc | 159.68B |
Market Cap Related Metrics
| PS Ratio | 1.340 |
| Price | 11.71 |
| Earnings Yield | -119.6% |